Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NAD Refers Central Coast Nutraceuticals’ Colotox Ads To FTC And FDA

This article was originally published in The Tan Sheet

Executive Summary

The National Advertising Division will refer Central Coast Nutraceuticals' Colotox advertising to the Federal Trade Commission and FDA for review after the firm failed to respond to an inquiry
Advertisement

Related Content

NAD reviews Colotox
NAD reviews Colotox
NAD reviews Colotox
NAD refers prostate supplement ad to FTC, FDA
NAD refers prostate supplement ad to FTC, FDA
NAD refers prostate supplement ad to FTC, FDA
ERSP Refers Premier Partners’ Teeth Whitening Ad To FTC
Nutraceuticals International Spurns NAD Review
ERSP Refers Premier Partners’ Teeth Whitening Ad To FTC
NAD’s Excedrin Review Gives Novartis A Headache

Topics

Advertisement
UsernamePublicRestriction

Register

PS102613

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel